SCHEMBL5140957

SCHEMBL5140957

CC(C)(C)OC(=O)Nn1cccc1C1CCCN(C(=O)OCc2ccccc2)C1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ BCL9 O00512 7/20 0.47
▸ CTNNB1 P35222 7/20 0.47
▸ JAK2 O60674 2/20 0.47
▸ JAK1 P23458 2/20 0.47
▸ TYK2 P29597 2/20 0.47
▸ JAK3 P52333 2/20 0.47
▸ ITGB3 P05106 1/20 0.44
▸ ITGA2B P08514 1/20 0.44
▸ PDE4B Q07343 2/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ HTT P42858 1/20 0.43
▸ USP30 Q70CQ3 1/20 0.42
▸ PARP1 P09874 1/20 0.42
▸ CTSL P07711 1/20 0.42
▸ CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5140956 1.00 BCL9 (0.47) BCL9CTNNB1JAK2JAK1TYK2
SCHEMBL14312873 0.91 PDE4B (0.47) JAK2JAK1PDE4BSMN1; SMN2NPC1
SCHEMBL14313170 0.81 BCL9 (0.44) BCL9CTNNB1JAK2JAK1TYK2
SCHEMBL26602429 0.79 USP30 (0.53) BCL9CTNNB1JAK2JAK1TYK2
SCHEMBL2063481 0.79 USP30 (0.58) ITGB3ITGA2BPDE4BSMN1; SMN2NPC1
SCHEMBL2063483 0.79 USP30 (0.58) ITGB3ITGA2BPDE4BSMN1; SMN2NPC1
SCHEMBL6128873 0.79 USP30 (0.58) ITGB3ITGA2BPDE4BSMN1; SMN2NPC1
SCHEMBL15669949 0.79 USP30 (0.53) BCL9CTNNB1JAK2JAK1TYK2
SCHEMBL14514789 0.78 ACKR3 (0.56) ITGB3ITGA2BPDE4BSMN1; SMN2NPC1
SCHEMBL14145058 0.77 PDE4B (0.54) BCL9CTNNB1JAK2JAK1TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1945222-A2 PYRROLO[2,1-F] [1,2,4] TRIAZIN-4-YLAMINES IGF-1R KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND OTHER HYPERPROLIFERATIVE DISEASES Bayer HealthCare AG (DE) 2008-07-23 — — EP disclosed
WO-2007056170-A2 PYRROLO[2,1-F] [1,2,4] TRIAZIN-4-YLAMINES IGF-1R KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND OTHER HYPERPROLIFERATIVE DISEASES BAYER HEALTHCARE AG (DE) 2007-05-18 — — WO disclosed
Send feedback